Evaluation of commercial immunodiffusion reagents for detecting serum anti-Paracoccidioides antibodies.


Journal

Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456

Informations de publication

Date de publication:
2024
Historique:
received: 11 03 2024
accepted: 29 04 2024
medline: 29 5 2024
pubmed: 29 5 2024
entrez: 29 5 2024
Statut: epublish

Résumé

Accurate diagnosis of paracoccidioidomycosis is crucial for improving patient outcomes. Paracoccidioides antibody detection by double immunodiffusion (DID) is a convenient diagnostic tool, but testing performance can vary based on certain factors. We assessed DID performance using a commercially prepared Paracoccidioides reagents (IMMY, USA), involving 40 serum specimens, including 20 from patients with proven paracoccidioidomycosis and 20 from patients without the disease. The DID test demonstrated a sensitivity of 90% (95% CI=68%-99%) and a specificity of 100% (95% CI=83%-100%). Our findings suggest that DID using commercial reagents may provide a feasible tool with satisfactory testing performance for anti-Paracoccidioides antibody detection.

Sections du résumé

BACKGROUND BACKGROUND
Accurate diagnosis of paracoccidioidomycosis is crucial for improving patient outcomes. Paracoccidioides antibody detection by double immunodiffusion (DID) is a convenient diagnostic tool, but testing performance can vary based on certain factors.
METHODS METHODS
We assessed DID performance using a commercially prepared Paracoccidioides reagents (IMMY, USA), involving 40 serum specimens, including 20 from patients with proven paracoccidioidomycosis and 20 from patients without the disease. The DID test demonstrated a sensitivity of 90% (95% CI=68%-99%) and a specificity of 100% (95% CI=83%-100%).
CONCLUSIONS CONCLUSIONS
Our findings suggest that DID using commercial reagents may provide a feasible tool with satisfactory testing performance for anti-Paracoccidioides antibody detection.

Identifiants

pubmed: 38808801
pii: S0037-86822024000100705
doi: 10.1590/0037-8682-0094-2024
pii:
doi:

Substances chimiques

Antibodies, Fungal 0
Reagent Kits, Diagnostic 0

Types de publication

Journal Article Evaluation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007052024

Auteurs

Regielly Caroline Raimundo Cognialli (RCR)

Universidade Federal do Paraná, Hospital de Clínicas, Curitiba, PR, Brasil.

Diego H Caceres (DH)

Center of Expertise in Mycology Radboudumc/CWZ. Nijmegen, the Netherlands.
Universidad del Rosario, Studies in Translational Microbiology and Faculty of Medical Sciences, Emerging Diseases Research Group. Bogota, Colombia.
IMMY. Norma, OK, United States of America.

Flávio de Queiroz Telles (FQ)

Universidade Federal do Paraná, Hospital de Clínicas, Departamento de Saúde Coletiva, Curitiba, PR, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH